Dopamine
(CTENFNNZBMHDDG-UHFFFAOYSA-N)
Structure
- SMILES
- NCCc1ccc(c(c1)O)O.Cl
- Molecular Formula:
- C8H12ClNO2
- Molecular Weight:
- 189.639
- Log P:
- 2.1013
- Hydrogen Bond Acceptor:
- 3
- Hydrogen Bond Donor:
- 4
- TPSA:
- 66.48
- CAS Number(s):
- 62-31-7
Synonym(s)
1.
Dopamine
2.
Hydroxytyramine
3.
3,4-Dihydroxyphenethylamine
4.
4-(2-Aminoethyl)-1,2-benzenediol
5.
Dopamine Hydrochloride
6.
Intropin
7.
3,4 Dihydroxyphenethylamine
8.
Hydrochloride, Dopamine
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Medication Error | FAERS: 7 | US FAERS | |
| 2 | Hypotension | FAERS: 5 | US FAERS | |
| 3 | Cardiac Arrest | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 4 | Extravasation | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 5 | Incorrect dose administered | FAERS: 3 | US FAERS | |
| 6 | Mydriasis | FAERS: 3 | US FAERS | |
| 7 | Pallor | FAERS: 3 | US FAERS | |
| 8 | Pharmaceutical product complaint | FAERS: 3 | US FAERS | |
| 9 | Tachycardia | FAERS: 3 | US FAERS | |
| 10 | Congenital Hypothyroidism | FAERS: 2 | US FAERS | |
| 11 | Device occlusion | FAERS: 2 | US FAERS | |
| 12 | Dizziness | FAERS: 2 | US FAERS | |
| 13 | Drug ineffective | FAERS: 2 | US FAERS | |
| 14 | Flushing | FAERS: 2 | US FAERS | |
| 15 | Incorrect drug administration rate | FAERS: 2 | US FAERS | |
| 16 | Product label confusion | FAERS: 2 | US FAERS | |
| 17 | Product packaging confusion | FAERS: 2 | US FAERS | |
| 18 | Ventricular Fibrillation | FAERS: 2 | US FAERS | |
| 19 | Accidental overdose | FAERS: 1 | US FAERS | |
| 20 | Administration site extravasation | FAERS: 1 | US FAERS | |
| 21 | Anti-thyroid antibody positive | FAERS: 1 | US FAERS | |
| 22 | Atrial Fibrillation | FAERS: 1 | US FAERS | |
| 23 | Blood pressure inadequately controlled | FAERS: 1 | US FAERS | |
| 24 | Bradycardia | FAERS: 1 | US FAERS | |
| 25 | Chest Pain | FAERS: 1 | US FAERS | |
| 26 | Circumstance or information capable of leading to medication error | FAERS: 1 | US FAERS | |
| 27 | Device Failure | FAERS: 1 | US FAERS | |
| 28 | Device malfunction | FAERS: 1 | US FAERS | |
| 29 | Drug dispensing error | FAERS: 1 | US FAERS | |
| 30 | Erythema | FAERS: 1 | US FAERS | |
| 31 | Extremity necrosis | FAERS: 1 | US FAERS | |
| 32 | Feeding disorder neonatal | FAERS: 1 | US FAERS | |
| 33 | Gangrene | FAERS: 1 | US FAERS | |
| 34 | Hypothyroidism | FAERS: 1 | US FAERS | |
| 35 | Hypoventilation | FAERS: 1 | US FAERS | |
| 36 | Hypoxia | FAERS: 1 | US FAERS | |
| 37 | Induration | FAERS: 1 | US FAERS | |
| 38 | Infusion site phlebitis | FAERS: 1 | US FAERS | |
| 39 | Injection site extravasation | FAERS: 1 | US FAERS | |
| 40 | Intercepted product selection error | FAERS: 1 | US FAERS | |
| 41 | Medical device complication | FAERS: 1 | US FAERS | |
| 42 | Memory impairment | FAERS: 1 | US FAERS | |
| 43 | Overdose | FAERS: 1 | US FAERS | |
| 44 | Pain | FAERS: 1 | US FAERS | |
| 45 | Peripheral swelling | FAERS: 1 | US FAERS | |
| 46 | Pneumonia | FAERS: 1 | US FAERS | |
| 47 | Poor weight gain neonatal | FAERS: 1 | US FAERS | |
| 48 | Posturing | FAERS: 1 | US FAERS | |
| 49 | Product expiration date issue | FAERS: 1 | US FAERS | |
| 50 | Product label issue | FAERS: 1 | US FAERS | |
| 51 | Product lot number issue | FAERS: 1 | US FAERS | |
| 52 | Product quality issue | FAERS: 1 | US FAERS | |
| 53 | Respiratory Failure | FAERS: 1 | US FAERS | |
| 54 | Respiratory distress | FAERS: 1 | US FAERS | |
| 55 | Screaming | FAERS: 1 | US FAERS | |
| 56 | Skin lesion | FAERS: 1 | US FAERS | |
| 57 | Skin necrosis | FAERS: 1 | US FAERS | |
| 58 | Toxicity to various agents | FAERS: 1 | US FAERS | |
| 59 | Unresponsive to stimuli | FAERS: 1 | US FAERS | |
| 60 | Cellulitis | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120262
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.